Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2001

View Archived Issues

Chiron sells gene therapy manufacturing facility to Cell Genesys; retains product rights

AeroGen reports product update

Vasogen begins immune modulation therapy clinical trials in CLL

NCI and Biovest may enter B-cell lymphoma vaccine collaboration

Centaur's rheumatoid arthritis drug advances to preclinical development

Diversa and IntraBiotics join forces to identify novel antiinfectives

Sanofi-Synthelabo to market Leuprogel in the U.S. and Canada

Voluntary suspension of Oxygent phase III trial announced by Alliance

Millennium/Wyeth-Ayerst antiinfective alliance identifies first preclinical candidate

Protherics provides interim update on product development

Phase III compound for liver diseases licensed by Interneuron

MMP inhibition as a therapeutic approach to preventing intracerebral hemorrhage after tPA therapy

Novazyme seeks orphan drug designation for MPS I therapy

Progress report on Metabolic's obesity and diabetes programs

Inhibitors of p38 kinase and their use disclosed by Scios

Recent patent covers hydroxamic acid-based MMP inhibitors and their therapeutic use

More on bacterial enzyme inhibitors under study at GlaxoSmithKline

Immunosuppressants acting as P2X7 receptor antagonists claimed by AstraZeneca

Soluble inhibitors of protein kinase C designed at AstraZeneca for wide range of disorders

Provalis obtains U.K. marketing rights to Pennsaid topical solution

New ACAT inhibitors in development at Sumitomo

Prototypical selective mglu5 antagonist displays anxiolytic-like effects

Abgenix further extends antibody collaborations with Pfizer, Amgen

Nonprostanoid PGI2 agonist with antiplatelet effects and favorable PK profile

Triptolide prodrug is highly effective in lethal murine GVHD model

Theratechnologies seeks clearance to initiate two additional trials with ThGRF1-44

Phase II trial begins with Idec's antipsoriatic antibody IDEC-114

SciClone commences phase II study of Zadaxin as treatment for hepatocellular carcinoma

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...